AltheaDx Receives CLIA Certification
AltheaDx announces that they have successfully passed the State of California survey for CLIA (Clinical Laboratory Improvement Amendments) certification.
Read MorePosted by Clinical Lab Products | May 26, 2009 | Cancer, Miscellaneous |
AltheaDx announces that they have successfully passed the State of California survey for CLIA (Clinical Laboratory Improvement Amendments) certification.
Read MorePosted by Clinical Lab Products | Apr 23, 2009 | Cancer, Miscellaneous |
Celera Corp announced the presentation of data describing a novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer.
Read MorePosted by Clinical Lab Products | Apr 3, 2009 | Cancer, Miscellaneous |
The rapidly expanding portfolio of tumor markers
Read MorePosted by Clinical Lab Products | Mar 20, 2009 | Cancer, Miscellaneous |
The prostate cancer screening tests that have become an annual ritual for many men dont appear to reduce deaths from the disease among those with a limited life expectancy, according to early results of a major US study involving 75,000 men.
Read MorePosted by Clinical Lab Products | Mar 13, 2009 | Cancer, Miscellaneous |
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.
Read More